NJ S1756 | 2018-2019 | Regular Session

Note: Carry Foward to future A973
Note: Carry Over of previous S1051

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 5 2018 - 25% progression, died in committee
Action: 2018-02-05 - Introduced in the Senate, Referred to Senate Commerce Committee
Pending: Senate Commerce Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Sponsors


History

DateChamberAction
2018-02-05SenateIntroduced in the Senate, Referred to Senate Commerce Committee

Same As/Similar To

S1756 (Carry Over) 2018-02-05 - Introduced in the Senate, Referred to Senate Commerce Committee
S1051 (Carry Over) 2016-02-08 - Introduced in the Senate, Referred to Senate Commerce Committee
A4273 (Same As) 2018-06-27 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Subjects


New Jersey State Sources


Bill Comments

feedback